R1757
D-(−)-Ribose
98%
Sinónimos:
D-Ribose
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula empírica (notación de Hill):
C5H10O5
Número CAS:
Peso molecular:
150.13
UNSPSC Code:
12352201
NACRES:
NA.22
PubChem Substance ID:
EC Number:
200-059-4
Beilstein/REAXYS Number:
1723081
MDL number:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
assay
98%
optical activity
[α]20/D −19.7°, c = 4 in H2O
mp
88-92 °C (lit.)
SMILES string
OC[C@@H](O)[C@@H](O)[C@@H](O)C([H])=O
InChI
1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5-/m0/s1
InChI key
PYMYPHUHKUWMLA-LMVFSUKVSA-N
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Raman K Sharma et al.
Bioorganic & medicinal chemistry, 20(23), 6821-6830 (2012-10-27)
A series of peracetylated O-aryl α,β-d-ribofuranosides have been synthesized and an efficient biocatalytic methodology has been developed for the separation of their anomers which was otherwise almost impossible by column chromatographic or other techniques. The incubation of 2,3,5-tri-O-acetyl-1-O-aryl-α,β-d-ribofuranoside with Lipozyme®
Carine Baraguey et al.
Organic & biomolecular chemistry, 11(16), 2638-2647 (2013-03-05)
The pivaloyloxymethyl (PivOM) group is a biolabile 2'-O-ribose protection that is under development in a prodrug-based approach for siRNA applications. Besides an expected cellular uptake, nucleic acid sequences carrying PivOM showed also increased nuclease resistance and, in most cases, an
Xiang-Guo Li et al.
Chemical communications (Cambridge, England), 49(35), 3682-3684 (2013-03-29)
Peptide glycosylation with 5-deoxy-5-[(18)F]fluororibose was translated into preclinical settings. The novel (18)F-labeled Siglec-9 peptide was produced using an automated synthesis procedure. The (18)F-labeled Siglec-9 peptide showed favorable binding in the animal model of inflammation in vivo.